StockData
Ascend Wellness Holdings, Inc. logo

Ascend Wellness Holdings, Inc. (AAWH) stock

AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.39−0.00 (-0.73%)

Close on Oct 19, 2026Market cap $79.60MP/E –Yield –

Earnings

Ascend Wellness's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$130.00M
+4.3% on a year earlier
EPS, Q3 FY2026
-$0.14
-$0.13 a year earlier
Latest guidance
Issued
Nov 12, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Ascend Wellness's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$130.00M+4.3%-$0.14Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026during market hours$126.10M-0.9%-$0.05Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours$116.90M-8.7%-$0.15Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025during market hours$124.70M-11.9%-$0.13Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours$127.30M–-$0.12Release
Q1 FY2025ended Mar 31, 2025May 12, 2025during market hours$128.00M–-$0.09Release
Q4 FY2024ended Dec 31, 2024Mar 12, 2025during market hours$136.00M––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$141.60M––Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024before the open–––Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Ascend Wellness's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueQ4 FY2026+1% – +2%–NewNov 12, 2026
capital expendituresFY2026$20.00M–NewNov 12, 2026

Guidance vs results

The last range Ascend Wellness gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue growth+2% – +4%+4.25%Above range
Q2 FY2026Revenue growth+2% – +3%-0.94%Below range

Guidance history

Every forecast Ascend Wellness put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 12, 2026capital expendituresFY2026$20.00MNew
Nov 12, 2026revenueQ4 FY2026+1% – +2%New
Aug 12, 2026revenueQ3 FY2026+2% – +4%New
May 13, 2026revenueQ2 FY2026+2% – +3%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Ascend Wellness filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Update
  12. Results
  13. News
  14. News
  15. Update

See a number that looks wrong?